14th World ADC London 2024

We find ourselves at the cutting edge of oncology innovation, with the ADC field booming with excitement due to the constant eflux of clinical progress and a plethora of high-value collaborations.

As such the 14th World ADC London 2024 returns this March as a crucial touchpoint for all antibody drug conjugate developers across Europe.

This meeting is the place where innovation meets collaboration to drive antibody-drug conjugates forward and transform cancer therapy as we know it. Uniting 600+ industry experts and ADC newcomers, this is a conversation you can't afford to miss.

Take a look at the full agenda here.

Embark on a knowledge-rich adventure as we explore the intricate nuances of ADC development. From the initial stages of target identification and antibody engineering to the complexities of clinical trials and CMC strategies to navigating commercialisation, expect to leave this event with a comprehensive understanding of the entire ADC lifecycle.

Whether you are pioneering ADC discoveries, accelerating your conjugate through preclinical and clinical development, or optimising your CMC efforts, this is your chance to ahead of the curve with the high-quality and invaluable guidance of the supportive ADC community.

14th World ADC London 2024

ExCel London
Royal Victoria Dock, 1 Western Gateway
London, E16 1XL

12th - 15th March, 2024